Gilead Sciences Inc (GILD)
89.80
+1.17
(+1.32%)
USD |
NASDAQ |
Nov 21, 16:00
89.80
0.00 (0.00%)
After-Hours: 20:00
Gilead Sciences Profit Margin (Quarterly): 16.61% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 16.61% |
| June 30, 2024 | 23.21% |
| March 31, 2024 | -62.37% |
| December 31, 2023 | 20.09% |
| September 30, 2023 | 30.92% |
| June 30, 2023 | 15.84% |
| March 31, 2023 | 15.90% |
| December 31, 2022 | 22.20% |
| September 30, 2022 | 25.40% |
| June 30, 2022 | 18.27% |
| March 31, 2022 | 0.29% |
| December 31, 2021 | 5.27% |
| September 30, 2021 | 34.93% |
| June 30, 2021 | 24.48% |
| March 31, 2021 | 26.92% |
| December 31, 2020 | 20.90% |
| September 30, 2020 | 5.47% |
| June 30, 2020 | -64.92% |
| March 31, 2020 | 27.96% |
| December 31, 2019 | 45.86% |
| September 30, 2019 | -20.79% |
| June 30, 2019 | 33.07% |
| March 31, 2019 | 37.40% |
| December 31, 2018 | 0.05% |
| September 30, 2018 | 37.47% |
| Date | Value |
|---|---|
| June 30, 2018 | 32.17% |
| March 31, 2018 | 30.23% |
| December 31, 2017 | -64.97% |
| September 30, 2017 | 41.74% |
| June 30, 2017 | 43.03% |
| March 31, 2017 | 41.54% |
| December 31, 2016 | 42.46% |
| September 30, 2016 | 44.40% |
| June 30, 2016 | 44.97% |
| March 31, 2016 | 45.75% |
| December 31, 2015 | 55.06% |
| September 30, 2015 | 55.46% |
| June 30, 2015 | 54.49% |
| March 31, 2015 | 57.06% |
| December 31, 2014 | 47.68% |
| September 30, 2014 | 45.20% |
| June 30, 2014 | 55.94% |
| March 31, 2014 | 44.55% |
| December 31, 2013 | 25.37% |
| September 30, 2013 | 28.34% |
| June 30, 2013 | 27.92% |
| March 31, 2013 | 28.53% |
| December 31, 2012 | 29.48% |
| September 30, 2012 | 27.84% |
| June 30, 2012 | 29.58% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-64.92%
Minimum
Jun 2020
45.86%
Maximum
Dec 2019
12.66%
Average
20.49%
Median
Profit Margin (Quarterly) Benchmarks
| Eli Lilly and Co | 8.48% |
| Merck & Co Inc | 18.95% |
| Pfizer Inc | 25.22% |
| Vertex Pharmaceuticals Inc | 37.71% |
| Amgen Inc | 33.28% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 0.64% |
| Return on Assets | 0.22% |
| Return on Invested Capital | 0.29% |
| Gross Profit Margin (Quarterly) | 79.14% |
| Operating Margin (Quarterly) | 41.66% |
| Return on Net Operating Assets | 0.28% |